Vitamin D Testing Market Size, Share & COVID-19 Impact Analysis, By Product (25-Hydroxy Vitamin D Testing, 1,25-Dihydroxy Vitamin D Testing, and 24,25-Dihydroxy Vitamin D Testing), By Application (Clinical Testing and Research Testing), By End-User (Standalone Clinical Laboratories, Hospitals & Clinics, Others) and Regional Forecast, 2022-2029

The global vitamin D testing market size was valued at USD 600.2 million in 2021. The market is projected to grow from USD 625.0 million in 2022 to USD 871.7 million by 2029, exhibiting a CAGR of 4.9% during the forecast period. The global COVID-19 pandemic has been unprecedented and staggering, with vitamin D testing experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. Based on our analysis, the global market exhibited a decline of 9.0% in 2020 as compared to 2019.

Increasing sedentary lifestyles and less exposure to sunlight are resulting in the rising prevalence of vitamin D deficiency in developed and emerging countries. For instance, according to an article published by BioMed Central Ltd., the prevalence of vitamin D deficiency among the Indian population was almost 67.0% in 2021.

This, along with the clinically established connection between several serious and chronic diseases with deficiency of vitamin D, is increasing the demand and adoption of the products used in vitamin D tests during the study period. Additionally, rising initiatives for the awareness regarding the level of vitamins, such as vitamin D, in both developing and developed nations and the emergence of new research demonstrating the importance of vitamin D in an individual’s overall health are propelling the vitamin D testing market growth. This factor, coupled with increasing investments by major players in research and development for new testing technologies, is also boosting the market's growth globally.

COVID-19 IMPACT

Decline in Number of Routine Vitamin D Tests During the Pandemic Negatively Affected Market Growth

The outbreak of COVID-19 had a negative impact on the market. Several key market players, including DiaSorin S.p.A., Abbott, and others, witnessed a significant decline in the revenue from their vitamin testing products. For instance, DiaSorin S.p.A. experienced a decline of 25.9% in the sales of products used in vitamin D tests in 2020 as compared to the previous fiscal year. Also, Abbott witnessed a decline of 3.9% in the revenue of the core laboratory segment in 2020 as compared to 2019.

Additionally, stringent lockdown and COVID-19 restrictions resulted in a significant decrease in routine blood tests, including vitamin D tests and lipid profile. This also resulted in negative market growth during the pandemic. For instance, according to a research article published by NCBI in 2020, it was reported that apart from the COVID-19 test, the overall testing volumes in the laboratory were found to have reduced during the pandemic.

However, according to a number of KOL interviews, it was reported that there had been a tremendous rise in patient volume during 2021. Also, increased health awareness of the post-COVID-19 situation and the introduction of advanced point of care testing kits are fostering the adoption rate of devices during the study period. Also, the key players operating in the market experienced a significant increase in revenue and returned to their pre-pandemic level in 2021. For instance, DiaSorin S.p.A. experienced an increase of 9.4% in the sales of products used in vitamin D tests as compared to 2020.

LATEST TRENDS

Request a Free sample to learn more about this report.

Emphasis Toward Quantitative Determination of 24,25-dihydroxy Vitamin D for Significant Evaluation of Vitamin D

24,25-dihydroxy vitamin D is a major form of vitamin D that is closely linked with the 1,25-dihydroxyvitamin D. Additionally, the ratio of 25-hydroxy vitamin D and 24,25-dihydroxy vitamin D has the clinical significance of determining the level of vitamin D in the human body. Also, according to a number of research publications and KOL interviews, it was reported that 24,25-dihydroxy vitamin D is effective in fracture healing. As a result, recent and ongoing advances in R&D are focusing on determining the level of 24,25-dihydroxy vitamin D.

Along with this, a recent trend was observed for adopting the point-of-care testing kits in place of lab-based tests. According to an article published by Ipsos in 2022, it was reported that several distinct advantages, including lower turn-around time, ease of use, and fewer requirements of professional guidance, are some of the factors for the preferential shift from lab-based tests to point-of-care tests.

DRIVING FACTORS

Rising Prevalence of Vitamin D Deficiency and Associated Diseases to Lead to Market Growth

The increasing prevalence of vitamin D deficiency and the rising prevalence of associated diseases, including osteoporosis and Inflammatory Bowel Disease (IBD) are some of the major factors resulting in the increasing demand for this procedure. For instance, according to an article published by WebMD LLC in April 2020, it was reported that the global prevalence of IBD is 396 cases per 100,000 persons annually. Also, this huge patient population suffering from vitamin D deficiency is seeking medical attention for the treatment of vitamin D deficiency and resulting in a rising economic burden. Eventually, this led to increased initiatives for a number of awareness campaigns regarding the importance of vitamin D by the government and other for-profit and non-profit organizations.

For instance, according to a report published by The Indian Express Ltd., in 2021, Royal DSM, a nutrition firm, launched a digital-led campaign in India with the goal of raising awareness about the importance of increasing vitamin D levels through good nutrition. This is responsible for the growing adoption of routine vitamin D testing and fueling the market growth during the study period.

RESTRAINING FACTORS

Growing Initiatives to Limit the Overuse of Vitamin D Testing to Limit Market Growth

Vitamin D deficiency is one of the most critical factors linked to the overall condition of health of an individual. However, a marked increase was observed in repetitive testing in the developed countries, including the U.S., Germany, and others. This is resulting in the overuse of healthcare resources, such as test kits, reagents, and others, and subsequently increases the healthcare burdens over z period of time.

Thus, a number of countries implemented certain regulatory guidelines regarding the vitamin testing frequency and usage of test kits. This significantly decreased the overutilization of healthcare resources as well as expenses and subsequently hindered the market growth during the study period. For instance, according to a study published by the Royal College of General Practitioners in 2021, a decrease of around 23.3% in vitamin D tests was observed after providing a multi-level intervention program based on training, monitoring, and feedback on 23 primary care health centers in the Netherlands.

Additionally, the high cost associated with the test is also hindering the adoption of vitamin D tests among the general population in the emerging countries, including Brazil, South Africa, and others. For instance, according to KINGS COLLEGE HOSPITAL in Dubai, the average procedural cost of a vitamin D test along with consultation is around USD 41.0.

SEGMENTATION

By Product Analysis

To know how our report can help streamline your business, Speak to Analyst

25-Hydroxy Vitamin D Test to Hold Dominant Position with Rising Vitamin D Deficiency

Based on product, the market is segmented into 25-hydroxy vitamin D testing, 1,25-dihydroxy vitamin D testing, and 24,25-dihydroxy vitamin D testing. 25-hydroxy vitamin D test dominated the market in 2021 and is anticipated to hold the dominant position during the study period. Determining the level of 25-hydroxy vitamin D is recognized as the gold standard of vitamin D tests. Moreover, the rising prevalence of vitamin D deficiency and insufficiency is surging the demand for this testing around the globe and subsequently supporting the segmental dominance of this segment. Also, diversified application of 25-hydroxy vitamin D for the nutritional assessment has been instrumental in the growth of this segment.

On the other hand, 1,25-dihydroxy vitamin D testing is anticipated to grow with the highest CAGR during the study period. Increasing application of 1,25-dihydroxy vitamin D in the diagnosis of sarcoidosis, and renal dysfunction, in combination with parathyroid hormone, is fueling the adoption rate of this test type. For instance, according to the American Lung Association, in 2020, almost 0.2 million sarcoidosis cases were diagnosed in the U.S. per year.

By Application Analysis

Increasing Application of Vitamin D Test Boosts Clinical Testing

Based on application, the market is segmented into clinical testing and research testing. The clinical testing segment held the lion’s share in the market in 2021. The increasing prevalence of vitamin D deficiency, along with rising initiatives for the awareness of this testing, is resulting in a higher demand for vitamin D test procedures. Also, the introduction of advanced point-of-care testing kits for the quantitative diagnosis of vitamin D also drives the segmental growth during the study period.

On the other hand, increasing investment by the market players for the introduction of advanced test kits along with the growing utilization of vitamin D tests in a number of healthcare research procedures is anticipated to boost the growth of the research testing segment significantly.

By End-User Analysis

Availability of Advanced Patient Care in Standalone Clinical Laboratories to Propel the Vitamin D Testing Market Outlook

Based on end-user, the market is categorized into standalone clinical laboratories, hospitals & clinics, and others. Vitamin D test is generally prescribed by general practitioners and internal medicine practitioners. However, this test is done at standalone clinical laboratories due to the presence of advanced laboratory equipment, reagents, and others. This eventually fueled the segmental growth during the study period.

Also, increasing investment for the expansion of the standalone clinical laboratories is also boosting the growth opportunity globally. For instance, Mayo Clinic invested USD 49.0 million in 2021 for the laboratory expansion project in Rochester.

The hospitals & clinics segment is also anticipated to grow with a significant CAGR during the study period. Increasing initiatives for the development of hospital infrastructure and a rising number of research surveys done in hospital and clinical settings are anticipated to support the growth of this segment.

REGIONAL INSIGHTS

To get more information on the regional analysis of this market, Request a Free sample

The market in Europe stood at USD 215.0 million in 2021. This region accounted for the major vitamin D testing market share in the global market. Approval of a large number of point of care testing products by the regulatory authority of this region, along with the increasing prevalence of vitamin D deficiency, is fueling the demand and adoption of the products in this region. For instance, according to an article published by the National Library of Medicine in 2019, it was reported that around 30.0-60.0% of the people in western, southern and eastern Europe were suffering from vitamin D deficiency.

North America accounted for the second position in value in the global market. Increasing prevalence of chronic kidney disease is fueling the demand for diagnosis of 1,25-dihydroxy vitamin D. For instance, according to according to the U.S. Department of Health & Human Services, approximately 15.0% of the U.S. adults were suffering from CKD in 2021. This, in turn, is increasing the adoption rate of vitamin D diagnostics products and subsequently bolstering the market growth in this region.

Asia Pacific is expected to emerge as the fastest-growing region during the forecast period. Developing healthcare infrastructure along with rising penetration of these products in Chinese and Japanese markets is fostering the high growth rate of this region.

Furthermore, Latin America and the Middle East & Africa are likely to witness a significant CAGR during the study period. The presence of a large patient population in these regions and inorganic growth strategies, including mergers and acquisitions between the major players and the regional for-profit and non-profit organizations are anticipated to fuel the market growth in these regions. For instance, in October 2020, BIOMÉRIEUX collaborated with the African Union Member States (AMSP) to supply high-quality diagnostics, consumables, and medical equipment to the African community.

KEY INDUSTRY PLAYERS

Advanced Product Offerings & Geographical Expansion to Help Players Gain Top Position

The market structure is consolidated, with a few players operating in the market. F. Hoffmann-La Roche Ltd, DiaSorin S.p.A., and Abbott account for the lion’s share in the market. The introduction of advanced cutting-edge technology to provide precise results to the patient is one of the major factors for the market dominance of these players. For instance, in January 2022, F. Hoffmann-La Roche Ltd. introduced Cobas Infinity Edge, a cloud-based platform for integrating and managing point-of-care data available for use in clinical settings worldwide.

Other prominent players operating in the market are BIOMÉRIEUX, Beckman Coulter, Inc., Siemens Healthcare GmbH, Quidel Corporation, Thermo Fisher Scientific Inc., RECIPE Chemicals + Instruments GmbH, and Immunodiagnostic Systems Holdings PLC.

LIST OF KEY COMPANIES PROFILED:

• F. Hoffmann-La Roche Ltd. (Switzerland)


• DiaSorin S.p.A. (Italy)


• Abbott (U.S)


• bioMérieux SA (France)


• Siemens Healthcare GmbH (Germany)


• Beckman Coulter, Inc. (U.S)


• Quidel Corporation (U.S)


• Thermo Fisher Scientific Inc. (U.S)


• RECIPE Chemicals + Instruments GmbH (Germany)

KEY INDUSTRY DEVELOPMENTS:

• May 2020: Abbott announced the availability of ID NOW in the U.S., a point-of-care quick test that provides results in minutes rather than taking days or weeks to deliver the test results.


• March 2020 – Thermo Fisher Scientific Inc. announced the availability of Cascadion SM Clinical Analyzer for Cascadion SM 25-hydroxy vitamin D assay in the U.S. with an aim to expand its brand presence. 

REPORT COVERAGE

An Infographic Representation of Vitamin D Testing Market

View Full Infographic

To get information on various segments, share your queries with us

The global market research report provides a detailed analysis and focuses on crucial aspects such as leading companies, applications, disposable types, and distribution channels. Also, the report offers insights into the market, current trends, and highlights the vital industry developments. In addition to the factors mentioned above, the report encompasses various factors that have contributed to the growth of the market in recent years.

Report Scope & Segmentation